Evidence map›Paper›PMID 42375371›Full record

ArticleFrontiers in immunology2026

Case Report: MECP2 and SH3KBP1 variants associated with autism spectrum disorder and immune dysregulation.

Arnau Marin-Llobet, Cristina Hernando-Davalillo, Heidy Baide-Mairena, Pilar Llobet-Agullo, Neus Fornes Garcia, Veronica Perez-Herrera, Anna Baro-Serrano

Abstract readCase Reports
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Arnau Marin-LlobetPediatric Neurology Unit, Hospital General de Granollers, Granollers, Spain.
Cristina Hernando-DavalilloDepartment of Genetic Medicine-Instituto Pediátrico de Enfermedades Raras (IPER), Hospital Sant Joan de Deu, Barcelona, Spain.
Heidy Baide-MairenaPediatric Neurology Unit, Hospital General de Granollers, Granollers, Spain.
Pilar Llobet-AgulloPediatric Allergy and Clinical Immunology Unit, Hospital General de Granollers, Granollers, Spain.
Neus Fornes GarciaDepartment of Genetic Medicine-Instituto Pediátrico de Enfermedades Raras (IPER), Hospital Sant Joan de Deu, Barcelona, Spain.
Veronica Perez-HerreraPediatric Cardiology Unit, Hospital General de Granollers, Granollers, Spain.
Anna Baro-SerranoPediatric Neurology Unit, Hospital General de Granollers, Granollers, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autism Spectrum Disorder (ASD) is a heterogeneous neurodevelopmental condition characterized by impairments in social communication and restricted, repetitive behaviors. Increasing evidence suggests that immune dysregulation may be present in a subset of individuals with neurodevelopmental disorders, although its role in ASD remains incompletely understood. We report two male patients with ASD, neurodevelopmental delay, immune dysregulation, and congenital cardiac anomalies. Genetic analysis using chromosomal microarray (CMA) identified distinct copy number variants on the X chromosome in each case. In patient 1, a duplication of the Xq28 region encompassing the

Indexed as

Adaptor Proteins, Signal TransducingAutism Spectrum DisorderMethyl-CpG-Binding Protein 2ChildChild, PreschoolChromosomes, Human, XDNA Copy Number VariationsGenetic Predisposition to DiseaseHumansMalePhenotypeAdaptor Proteins, Signal TransducingMECP2 protein, humanMethyl-CpG-Binding Protein 2autism spectrum disorder (ASD)chromosomal microarray (CMA) testingimmunodysregulationinborn errors immunityMECP2 duplication syndromeneurodevelopmental disordersSH3KBP1

Identifiers

PMID42375371
PMCPMC13310728

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.